MICAFUNGIN AS ANTI FUNGAL PROPHYLAXIS IN PATIENTS SUBJECTED TO ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS IN SPAIN (GETH-MIC)

被引:0
|
作者
Garcia Martin, L. [1 ]
Ferre, O. [1 ]
Lopez, F. [1 ]
Lopez-Sanchez, C. [2 ]
Ruiz-Campos, I [2 ]
Gomez, V [3 ]
Lopez-Jimenez, J. [4 ]
Serrano, D. [5 ]
Rubio, V [6 ]
Solano, C. [7 ]
Vazquez, L. [1 ]
机构
[1] Hosp Univ Salamanca, Salamanca, Spain
[2] Hosp Univ Vall dHebron, Barcelona, Spain
[3] Hosp Univ la Princesa, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Madrid, Spain
[5] Hosp Univ Gregorio Maranon, Barcelona, Spain
[6] Hosp Jerez de la Frontera, Cadiz, Spain
[7] Hosp Clin Univ Valencia, Cadiz, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PC-305
引用
收藏
页码:223 / 223
页数:1
相关论文
共 50 条
  • [41] Candida Intestinal Domination Precedes Fungal Infections Bloodstream in Allogeneic Hematopoietic Cell Transplant Patients
    Zhai, Bing
    Ola, Mihaela
    Tosini, Nicholas L.
    Joshowitz, Sari
    Littmann, Eric
    Morjaria, Sejal M.
    Peled, Jonathan U.
    van den Brink, Marcel R. M.
    Pamer, Eric G.
    Butler, Geraldine
    Taur, Ying
    Hohl, Tobias M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [42] Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic cell transplantation
    Barba, P.
    Rosillo, C.
    Huang, Y-T.
    Avila, A. M.
    Montoro, J.
    Malloy, M.
    Papanicolaou, G.
    Perales, M. -A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S33 - S34
  • [43] Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
    van Burik, JAH
    Ratanatharathorn, V
    Stepan, DE
    Miller, CB
    Lipton, JH
    Vesole, DH
    Bunin, N
    Wall, DA
    Hiemenz, JW
    Satoi, Y
    Lee, JM
    Walsh, TJ
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1407 - 1416
  • [44] Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant
    Huang, Xiaojun
    Chen, Huan
    Han, Mingzhe
    Zou, Ping
    Wu, Depei
    Lai, Yongrong
    Huang, He
    Chen, Xiequn
    Liu, Ting
    Zhu, Huanling
    Wang, Jianmin
    Hui, Jianda
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (10) : 1509 - 1516
  • [45] Systematic Anti-Mold Prophylaxis Results in Very Low Incidence of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
    Rosillo, Claudia
    Barba, Pere
    Huang, Yao-Ting
    Avila, Ana Maria
    Montoro, Juan
    Maloy, Molly
    Papanicolaou, Genovefa A.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S159 - S160
  • [46] Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients
    Ahmed, Rayaz
    Thakur, Sanghmitra
    Kapoor, Jyotsna
    Agrawal, Narendra
    Mehta, Pallavi
    Thekuddan, Shinto Francis
    Garg, Ambar
    Bhurani, Dinesh
    BLOOD, 2018, 132
  • [47] Antifungal prophylaxis with micafungin and bridging to inhaled liposomal amphotericin B after engraftment in patients undergoing allogeneic hematopoietic stem cell transplantation
    Rivera, D.
    De Ramon, C.
    Avendano, A.
    Carrillo, J.
    Caballero, D.
    Lopez, L.
    Ormazabal, I.
    Navarro, A.
    Martin, A.
    Vazquez, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S240 - S240
  • [48] Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients
    Liu, F.
    Wu, T.
    Wang, J. B.
    Cao, X. Y.
    Yin, Y. M.
    Zhao, Y. L.
    Lu, D. P.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) : 243 - 250
  • [49] ASSOCIATION BETWEEN DRUG TOLERABILITY AND ECONOMIC IMPACT FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
    Gao, X.
    Ji, X.
    Stephens, J. M.
    Schlamm, H.
    Tarallo, M.
    VALUE IN HEALTH, 2011, 14 (03) : A7 - A7
  • [50] Differences in Patterns of Infections Among Allogeneic Hematopoietic Cell Transplant Patients Receiving Letermovir Prophylaxis for Cytomegalovirus
    Solh, Melhem
    Solomon, Scott R.
    Zhang, Xu
    Morris, Lawrence E.
    Bachier-Rodriguez, Lizamarie
    Holland, H. Kent
    Bashey, Asad
    BLOOD, 2022, 140 : 4745 - 4746